Oroxylin A reverses hypoxia-induced cisplatin resistance through inhibiting HIF-1α mediated XPC transcription
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oroxylin A reverses hypoxia-induced cisplatin resistance through inhibiting HIF-1α mediated XPC transcription
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-25
DOI
10.1038/s41388-020-01474-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Small-Molecule Modulators of the Hypoxia-Inducible Factor Pathway: Development and Therapeutic Applications
- (2019) Zhihong Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Oroxylin A increases the sensitivity of temozolomide on glioma cells by hypoxia-inducible factor 1α/hedgehog pathway under hypoxia
- (2019) Mian Wei et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway
- (2019) Hanbo Cao et al. Frontiers in Oncology
- Hypoxia-Inducible Factors as an Alternative Source of Treatment Strategy for Cancer
- (2019) Musbau Adewumi Akanji et al. Oxidative Medicine and Cellular Longevity
- Oroxylin A suppresses influenza A virus replication correlating with neuraminidase inhibition and induction of IFNs
- (2018) Jing Jin et al. BIOMEDICINE & PHARMACOTHERAPY
- Downregulation of RIF1 Enhances Sensitivity to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC) by Regulating Nucleotide Excision Repair (NER) Pathway
- (2018) Yong-Bin Liu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Novel Hypoxia-Inducible Factor 1α (HIF-1α) Inhibitors for Angiogenesis-Related Ocular Diseases: Discovery of a Novel Scaffold via Ring-Truncation Strategy
- (2018) Hongchan An et al. JOURNAL OF MEDICINAL CHEMISTRY
- Base and nucleotide excision repair facilitate resolution of platinum drugs-induced transcription blockage
- (2018) Jana Slyskova et al. NUCLEIC ACIDS RESEARCH
- Nucleotide Excision Repair Factor XPC Ameliorates Prognosis by Increasing the Susceptibility of Human Colorectal Cancer to Chemotherapy and Ionizing Radiation
- (2018) Liang-Bo Hu et al. Frontiers in Oncology
- Lung cancer: current therapies and new targeted treatments
- (2017) Fred R Hirsch et al. LANCET
- TP53 and MDM2 genetic alterations in non-small cell lung cancer: Evaluating their prognostic and predictive value
- (2016) Christophe Deben et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis
- (2016) Sheng-li Yang et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Oroxylin A reverses the drug resistance of chronic myelogenous leukemia cells to imatinib through CXCL12/CXCR7 axis in bone marrow microenvironment
- (2016) Wenjun Li et al. MOLECULAR CARCINOGENESIS
- Overview of Oroxylin A: A Promising Flavonoid Compound
- (2016) Lu Lu et al. PHYTOTHERAPY RESEARCH
- Anti-inflammatory effects of oroxylin A on RAW 264.7 mouse macrophages induced with polyinosinic-polycytidylic acid
- (2016) JI YOUNG LEE et al. Experimental and Therapeutic Medicine
- Hypoxia-inducible factor 1 promotes chemoresistance of lung cancer by inducing carbonic anhydrase IX expression
- (2016) Terumasa Sowa et al. Cancer Medicine
- Autophagy positively regulates DNA damage recognition by nucleotide excision repair
- (2015) Lei Qiang et al. Autophagy
- Synthesis and Biological Evaluation of Manassantin Analogues for Hypoxia-Inducible Factor 1α Inhibition
- (2015) Do-Yeon Kwon et al. JOURNAL OF MEDICINAL CHEMISTRY
- HIF-1α pathway: role, regulation and intervention for cancer therapy
- (2015) Georgina N. Masoud et al. Acta Pharmaceutica Sinica B
- Replication Stress and Chromatin Context Link ATM Activation to a Role in DNA Replication
- (2013) Monica M. Olcina et al. MOLECULAR CELL
- Oroxylin A reverses P-glycoprotein-mediated multidrug resistance of MCF7/ADR cells by G2/M arrest
- (2013) Litao Zhu et al. TOXICOLOGY LETTERS
- Oroxylin A improves the sensitivity of HT-29 human colon cancer cells to 5-FU through modulation of the COX-2 signaling pathway
- (2012) Jun Ha et al. Biochemistry and Cell Biology
- HIF1α regulated expression of XPA contributes to cisplatin resistance in lung cancer
- (2012) Yanbin Liu et al. CARCINOGENESIS
- Synthesis and Structure–Activity Relationship of (E)-Phenoxyacrylic Amide Derivatives as Hypoxia-Inducible Factor (HIF) 1α Inhibitors
- (2012) Ravi Naik et al. JOURNAL OF MEDICINAL CHEMISTRY
- Oroxylin A reverses CAM-DR of HepG2 cells by suppressing Integrinβ1 and its related pathway
- (2012) Binbin Zhu et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
- (2012) Gregg L. Semenza TRENDS IN PHARMACOLOGICAL SCIENCES
- Hypoxia-induced cisplatin resistance is reversible and growth rate independent in lung cancer cells
- (2011) Christoph Wohlkoenig et al. CANCER LETTERS
- Oroxylin a reverses multi-drug resistance of human hepatoma BEL7402/5-FU cells via downregulation of P-glycoprotein expression by inhibiting NF-κB signaling pathway
- (2011) Hui-Ying Yang et al. MOLECULAR CARCINOGENESIS
- Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma
- (2011) R-Y Liu et al. ONCOGENE
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Upregulation of Hypoxia-Inducible Factor-1α mRNA and its Clinical Significance in Non-small Cell Lung Cancer
- (2010) Tomofumi Yohena et al. Journal of Thoracic Oncology
- Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
- (2010) Alex Chang LUNG CANCER
- mTORC1 Signaling under Hypoxic Conditions Is Controlled by ATM-Dependent Phosphorylation of HIF-1α
- (2010) Hakan Cam et al. MOLECULAR CELL
- HIF-2 deletion promotes Kras-driven lung tumor development
- (2010) J. Mazumdar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Suppression of Hypoxia-Inducible Factor 2 Restores p53 Activity via Hdm2 and Reverses Chemoresistance of Renal Carcinoma Cells
- (2009) A. M. Roberts et al. CANCER RESEARCH
- Inhibition of HIF-1alpha activity by homeodomain-interacting protein kinase-2 correlates with sensitization of chemoresistant cells to undergo apoptosis
- (2009) Lavinia Nardinocchi et al. Molecular Cancer
- Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
- (2009) G L Semenza ONCOGENE
- Impaired DNA double-strand break repair contributes to chemoresistance in HIF-1 -deficient mouse embryonic fibroblasts
- (2008) R. Wirthner et al. CARCINOGENESIS
- Regulation of gene expression by hypoxia: Integration of the HIF-transduced hypoxic signal at the hypoxia-responsive element
- (2008) Stefan Kaluz et al. CLINICA CHIMICA ACTA
- Platinum Resistance: The Role of DNA Repair Pathways
- (2008) L. P. Martin et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started